Patrick John Flynn - 28 Nov 2022 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Director
Signature
/s/ Patrick J Flynn
Issuer symbol
NRXP
Transactions as of
28 Nov 2022
Net transactions value
+$14,662
Form type
4
Filing time
29 Nov 2022, 06:00:11 UTC
Previous filing
22 Nov 2022
Next filing
10 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRXP Common Stock, par value $0.001 per share Purchase $3,125 +2,500 +7.1% $1.25 37,709 28 Nov 2022 By Trust F1
transaction NRXP Common Stock, par value $0.001 per share Purchase $3,125 +2,500 +6.6% $1.25 40,209 28 Nov 2022 By Trust F2
transaction NRXP Common Stock, par value $0.001 per share Purchase $3,125 +2,500 +7.1% $1.25 37,709 28 Nov 2022 By Trust F3
transaction NRXP Common Stock, par value $0.001 per share Purchase $3,100 +2,500 +6.6% $1.24 40,209 28 Nov 2022 By Trust F4
transaction NRXP Common Stock, par value $0.001 per share Purchase $2,188 +1,750 $1.25 1,750 28 Nov 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by the Whitney Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
F2 Held by the Whitney Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
F3 Held by the Lindsay Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
F4 Held by the Lindsay Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.